
News|Videos|August 22, 2024
Perfluorohexyloctane ophthalmic solution in the treatment of dry eye
Author(s)David Hutton
At the World Ophthalmology Congress in Vancouver, Canada, John D. Sheppard, MD, MMSc, FACS, presented data on perfluorohexyloctane ophthalmic solution in the treatment of dry eye. He sat down with Ophthalmology Times to discuss the topic in further detail.
Advertisement
At the World Ophthalmology Congress in Vancouver, Canada, John D. Sheppard, MD, MMSc, FACS, presented data on perfluorohexyloctane ophthalmic solution in the treatment of dry eye. He sat down with Ophthalmology Times to discuss the topic in further detail.
Video Transcript:
Editor's note: The below transcript has been lightly edited for clarity.
John D. Sheppard, MD, MMSc, FACS:
*transcript in process
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Obstructive sleep apnea and glaucoma: What a 12.5-million-patient data set reveals
2
ChatGPT-5 overestimates macular hole surgery success, study finds
3
Bayer acquires Perfuse Therapeutics, partners with Iambic to expand ophthalmology and AI capabilities
4
Lesion growth rate reduction tops retina specialists' geographic atrophy treatment priorities
5


























